Assignee
BIOCON LTD
IN·90 granted patents·27 pending applications·525 citations·filing 1998–2025
Top patents by PatentIndex Score
117 records- 0195US8815247B2Targeted/immunomodulatory fusion proteinsBIOCON LTD·Filed 2013·Granted Aug 26, 2014·27 cites·1 claims
- 0294US7425578B2Immunoregulatory compounds and derivatives and methods of treating diseases therewithBIOCON LTD·Filed 2006·Granted Sep 16, 2008·21 cites·20 claims
- 0393US7605123B2Fatty acid formulations for oral delivery of proteins and peptides, and uses thereofBIOCON LTD·Filed 2005·Granted Oct 20, 2009·25 cites·15 claims
- 0492US9758582B2Anti-CTLA4 antibody-TGF-βRII targeted/immunomodulatory fusion proteinsBIOCON LTD·Filed 2016·Granted Sep 12, 2017·8 cites·1 claims
- 0592US7662773B2Natriuretic compounds, conjugates, and uses thereofBIOCON LTD·Filed 2003·Granted Feb 16, 2010·33 cites·78 claims
- 0691US12049632B2Anti-EGFR1-PD1 targeted/immunomodulatory fusion proteinBIOCON LTD·Filed 2021·Granted Jul 30, 2024·1 cites·3 claims
- 0791US7470663B2Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making sameBIOCON LTD·Filed 2006·Granted Dec 30, 2008·13 cites·5 claims
- 0891US2025011794A1Targeted/immunomodulatory fusion proteins and methods for making sameBIOCON LTD·Filed 2024·Application pending·0 cites
- 0990US9670285B2Monoclonal antibody and a method thereofBIOCON LTD·Filed 2015·Granted Jun 6, 2017·7 cites·4 claims
- 1090US7875700B2Cation complexes of insulin compound conjugates, formulation and uses thereofBIOCON LTD·Filed 2005·Granted Jan 25, 2011·13 cites·82 claims
- 1190US7648962B2Natriuretic compounds, conjugates, and uses thereofBIOCON LTD·Filed 2004·Granted Jan 19, 2010·36 cites·61 claims
- 1290US7423014B2Insulin conjugates for treating diabetes mellitusBIOCON LTD·Filed 2005·Granted Sep 9, 2008·16 cites·8 claims
- 1389US11028399B2CTLA4/PD1 targeted/immunomodulatory fusion proteinsBIOCON LTD·Filed 2019·Granted Jun 8, 2021·2 cites·2 claims
- 1489US10669346B2Monoclonal antibody and a method thereofBIOCON LTD·Filed 2018·Granted Jun 2, 2020·2 cites·12 claims
- 1589US10000573B2Monoclonal antibody and a method thereofBIOCON LTD·Filed 2017·Granted Jun 19, 2018·6 cites·9 claims
- 1689US6664095B1Solid state fermentationBIOCON LTD·Filed 2000·Granted Dec 16, 2003·62 cites·24 claims
- 1788US9217037B2Monoclonal antibody and a method thereofBIOCON LTD·Filed 2013·Granted Dec 22, 2015·8 cites·2 claims
- 1887US2024417483A1Monoclonal antibody and a method thereofBIOCON LTD·Filed 2024·Application pending·0 cites
- 1986US11028168B2Use of a CD6 binding partner and method based thereonBIOCON LTD·Filed 2018·Granted Jun 8, 2021·3 cites·8 claims
- 2086US10766963B2Fusion immunomodulatory proteins and methods for making sameBIOCON LTD·Filed 2018·Granted Sep 8, 2020·3 cites·6 claims
- 2185US11981743B2Monoclonal antibody and a method thereofBIOCON LTD·Filed 2020·Granted May 14, 2024·1 cites·11 claims
- 2285US7361772B2Process for the production of atorvastatin calciumBIOCON LTD·Filed 2003·Granted Apr 22, 2008·17 cites·11 claims
- 2384US7872095B2Insulin-oligomer conjugates, formulations and uses thereofBIOCON LTD·Filed 2005·Granted Jan 18, 2011·5 cites·20 claims
- 2484US6867306B2Process for the synthesis of atorvastatin form v and phenylboronates as intermediate compoundsBIOCON LTD·Filed 2001·Granted Mar 15, 2005·33 cites·7 claims
- 2583US10385348B2Epidermal growth factor receptor targeted/immunomodulatory fusion proteins and methods of use for themBIOCON LTD·Filed 2017·Granted Aug 20, 2019·2 cites·8 claims
- 2683US10144934B2Targeted/TGF-ßRII fusion proteins and methods for making sameBIOCON LTD·Filed 2017·Granted Dec 4, 2018·2 cites·14 claims
- 2783US2025368743A1Fusion immunomodulatory proteins and methods for making sameBIOCON LTD·Filed 2025·Application pending·0 cites
- 2882US9809651B2Method of treating cancer with an EGFR targeted immunomodulatory fusion proteinBIOCON LTD·Filed 2016·Granted Nov 7, 2017·2 cites·6 claims
- 2981US9988456B2Fusion immunomodulatory proteins and methods for making sameBIOCON LTD·Filed 2014·Granted Jun 5, 2018·5 cites·5 claims
- 3081US2024058263A1Formulations of antibodyBIOCON LTD·Filed 2023·Application pending·0 cites
- 3180US9340617B2Targeted/immunomodulatory fusion proteins and methods for making sameBIOCON LTD·Filed 2014·Granted May 17, 2016·2 cites·1 claims
- 3279US9856502B2Methods for controlling fucosylation levels in proteinsBIOCON LTD·Filed 2014·Granted Jan 2, 2018·6 cites·5 claims
- 3378US7196059B2Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewithBIOCON LTD·Filed 2003·Granted Mar 27, 2007·9 cites·34 claims
- 3478US6197573B1Solid state fermentationBIOCON LTD·Filed 1998·Granted Mar 6, 2001·71 cites·70 claims
- 3577US7166571B2Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing sameBIOCON LTD·Filed 2003·Granted Jan 23, 2007·6 cites·132 claims
- 3676US7119119B2Immunoregulatory compounds and derivatives and methods of treating diseases therewithBIOCON LTD·Filed 2005·Granted Oct 10, 2006·1 cites·5 claims
- 3775US6573385B1Process for manufacturing simvastatin and novel intermediates thereofBIOCON LTD·Filed 2002·Granted Jun 3, 2003·8 cites·8 claims
- 3874US12351636B2Fusion immunomodulatory proteins and methods for making sameBIOCON LTD·Filed 2020·Granted Jul 8, 2025·0 cites·2 claims
- 3974US7473366B2Process for the purification of macrolidesBIOCON LTD·Filed 2003·Granted Jan 6, 2009·9 cites·10 claims
- 4073US10189899B2Use of a CD6 binding partner and method based thereonBIOCON LTD·Filed 2014·Granted Jan 29, 2019·2 cites·6 claims
- 4172US8048924B2Methods and compositions employing 4-aminophenylacetic acid compoundsBIOCON LTD·Filed 2005·Granted Nov 1, 2011·1 cites·13 claims
- 4271US6603022B1Process for manufacturing Simvastatin and novel intermediates thereofBIOCON LTD·Filed 2003·Granted Aug 5, 2003·6 cites·26 claims
- 4371US2019321285A1Formulations of antibodyBIOCON LTD·Filed 2018·Application pending·0 cites
- 4470US2021290525A1Formulations of antibodyBIOCON LTD·Filed 2020·Application pending·0 cites
- 4569US11242401B2Monoclonal antibody and a method of use for the treatment of lupusBIOCON LTD·Filed 2017·Granted Feb 8, 2022·1 cites·7 claims
- 4669US11060097B2Immunotherapy methods using anti-PD-L1 antibodies in combination with EGFR1 targeted-TGF-beta immunomodulatory fusion proteinsBIOCON LTD·Filed 2019·Granted Jul 13, 2021·0 cites·4 claims
- 4769US7635675B2Micro-particle fatty acid salt solid dosage formulations for therapeutic agentsBIOCON LTD·Filed 2004·Granted Dec 22, 2009·5 cites·24 claims
- 4869US7169889B1Insulin prodrugs hydrolyzable in vivo to yield peglylated insulinBIOCON LTD·Filed 2000·Granted Jan 30, 2007·2 cites·25 claims
- 4969US6927047B1Manufacture and purification of mycophenolic acidBIOCON LTD·Filed 2000·Granted Aug 9, 2005·5 cites·10 claims
- 5068US6709846B1Methods of producing esters of mycophenolateBIOCON LTD·Filed 1999·Granted Mar 23, 2004·15 cites·20 claims
Showing the top 50 of 117 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when BIOCON LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →